Cited by 262Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease

Open access

Ma, Tao, Hoeffer, Charles A., Capetillo-Zarate, Estibaliz, Yu, Fangmin, Wong, Helen, Lin, Michael T., Tampellini, Davide, Klann, Eric, Blitzer, Robert D., Gouras, Gunnar K.·2010·PLoS ONE

DOI 10.1371/journal.pone.0012845PMC PMC2942840

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The mammalian target of rapamycin (mTOR) is an evolutionarily conserved Ser/Thr protein kinase that plays a pivotal role in multiple fundamental biological processes, including synaptic plasticity. We explored the relationship between the mTOR pathway and β-amyloid (Aβ)-induced synaptic dysfunction, which is considered to be critical in the pathogenesis of Alzheimer's disease (AD). METHODOLOGY/PRINCIPAL FINDINGS: We provide evidence that inhibition of mTOR signaling correlates with impairment in synaptic plasticity in hippocampal slices from an AD mouse model and in wild-type slices exposed to exogenous Aβ1-42. Importantly, by up-regulating mTOR signaling, glycogen synthase kinase 3 (GSK3) inhibitors rescued LTP in the AD mouse model, and genetic deletion of FK506-binding protein 12 (FKBP12) prevented Aβ-induced impairment in long-term potentiation (LTP). In addition, confocal microscopy demonstrated co-localization of intraneuronal Aβ42 with mTOR. CONCLUSIONS/SIGNIFICANCE: These data support the notion that the mTOR pathway modulates Aβ-related synaptic dysfunction in AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0012845

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Alzheimer’s disease
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCα, but Not S6K1
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,467
Translational control of gene expression
Sonenberg, N., Hershey, J. W. B., & Mathews, M. B. (2000) · Cold Spring Harbor Laboratory eBooks · Cited by 1,379
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 262

Developmental exposure to Pb2+ induces transgenerational changes to zebrafish brain transcriptome
Meyer, D. N., Crofts, E. J., Akemann, C., Gurdziel, K., Farr, R. L., Baker, B. B., Weber, D. N., & Baker, T. R. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125527 · Cited by 56
Regeneration in the nervous system with erythropoietin
Maiese, K. (2015) · Frontiers in bioscience · doi:10.2741/4408 · Cited by 54
Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway
Mencer, S., Kartawy, M., Lendenfeld, F. V., Soluh, H., Tripathi, M. K., Khaliulin, I., & Amal, H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01578-2 · Cited by 55
Rapid antidepressants stimulate the decoupling of GABAB receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η
Workman, E. R., Haddick, P. C. G., Bush, K. M., Dilly, G. A., Niere, F., Zemelman, B. V., & Raab‐Graham, K. F. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.165 · Cited by 53
Activation of mTOR in the spinal cord is required for pain hypersensitivity induced by chronic constriction injury in mice
Zhang, W., Sun, X., Bo, J.-H., Zhang, J., Liu, X., Wu, L., Ma, Z., & Gu, X. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.017 · Cited by 57
Decreased rabphilin 3A immunoreactivity in Alzheimer’s disease is associated with Aβ burden
Tan, M. G. K., Lee, C., Lee, J. H., Francis, P. T., Williams, R. J., Ramírez, M. J., Chen, C., Wong, P. T. ‐., & Lai, M. K. P. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.013 · Cited by 50
Pain-Relieving Effects of mTOR Inhibitor in the Anterior Cingulate Cortex of Neuropathic Rats
Um, S. W., Kim, M. J., Leem, J. W., Bai, S. J., & Lee, B. H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1245-z · Cited by 47
Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis
Sosanya, N. M., Brager, D. H., Wolfe, S., Niere, F., & Raab-Graham, K. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.011 · Cited by 49
Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach
Grados, M. A., Specht, M. W., Sung, H.-M., & Fortune, D. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.845553 · Cited by 49
Brain-specific suppression of AMPKα2 isoform impairs cognition and hippocampal LTP by PERK-mediated eIF2α phosphorylation
Yang, W., Zhou, X., Zimmermann, H. R., & Ma, T. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0739-z · Cited by 48
Self-citation
mTOR pathway: A potential therapeutic target for spinal cord injury
Ding, Y., & Chen, Q. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112430 · Cited by 53
Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice
Lennox, R., Flatt, P. R., & Gault, V. A. (2014) · Peptides · doi:10.1016/j.peptides.2014.08.014 · Cited by 47
Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes
Stanciu, G. D., Rusu, R. N., Bild, V., Filipiuc, L. E., Tamba, B.-I., & Ababei, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9050576 · Cited by 47
Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease
Meng, F., Dai, E., Yu, X., Zhang, Y., Chen, X., Liu, X., Wang, S., Wang, L., & Jiang, W. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.1057 · Cited by 47
Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer’s pathology
Kumar, P., Goettemoeller, A. M., Espinosa‐García, C., Tobin, B. R., Tfaily, A., Nelson, R. S., Natu, A., Dammer, E. B., Santiago, J. V., Malepati, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47028-7 · Cited by 53
Effects of rapamycin and TOR on aging and memory: implications for Alzheimer’s disease
Santos, R. X., Correia, S. C., Cardoso, S., Carvalho, C., Santos, M. S., & Moreira, P. I. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07262.x · Cited by 45
Early Selective Vulnerability of Synapses and Synaptic Mitochondria in the Hippocampal CA1 Region of the Tg2576 Mouse Model of Alzheimer's Disease
Balietti, M., Giorgetti, B., Casoli, T., Solazzi, M., Tamagnini, F., Burattini, C., Aicardi, G., & Fattoretti, P. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121711 · Cited by 50
Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine
Flood, D. G., Marek, G. J., & Williams, M. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.021 · Cited by 46
Memory Decline and Behavioral Inflexibility in Aged Mice Are Correlated With Dysregulation of Protein Synthesis Capacity
Yang, W., Zhou, X., & Ma, T. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00246 · Cited by 47
Self-citation
Alzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 43
Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice
Patel, S. P., Grizzell, J. A., Holmes, R., Zeitlin, R., Solomon, R., Sutton, T. L., Rohani, A., Charry, L. C., Iarkov, A., Mori, T., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00162 · Cited by 41
Astaxanthin Improved the Cognitive Deficits in APP/PS1 Transgenic Mice Via Selective Activation of mTOR
Huang, C., Wen, C., Yang, M., Li, A., Fan, C., Gan, D., Li, Q., Zhao, J., Zhu, L., & Lu, D. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09953-4 · Cited by 42
Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
Zhao, Y., Zhang, Y., Zhang, J., Zhang, X., & Yang, G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200114163636 · Cited by 40
Environmental enrichment enhances autophagy signaling in the rat hippocampus
Takahashi, T., Shimizu, K., Shimazaki, K., Toda, H., & Nibuya, M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.026 · Cited by 39
Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?
Shirooie, S., Nabavi, S. F., Dehpour, A. R., Belwal, T., Habtemariam, S., Argüelles, S., Sureda, A., Daglia, M., Tomczyk, M., Sobarzo‐Sánchez, E., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.004 · Cited by 37
Neuritin can normalize neural deficits of Alzheimer’s disease
An, K., Jung, J. H., Jeong, A. Y., Kim, H. G., Jung, S., Lee, K., Kim, H. J., Kim, S.-J., Jeong, T.-Y., Son, Y., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.478 · Cited by 35
New insights on the effects of ionic liquid structural changes at the gene expression level: Molecular mechanisms of toxicity in Daphnia magna
Jeremias, G., Jesus, F. T., Ventura, S. P. M., Gonçalves, F. J. M., Asselman, J., & Pereira, J. L. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124517 · Cited by 36
Nootropic effects of LSD: Behavioral, molecular and computational evidence
Ornelas, I. M., da Silva, F. A. C., Wießner, I., Marcos, E., de Araújo, D. B., Goto‐Silva, L., Nascimento, J. M., Silva, S. R. B., Costa, M., Falchi-Carvalho, M., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114148 · Cited by 37
Astrocytes in Down Syndrome Across the Lifespan
Ponroy Bally, B., & Murai, K. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.702685 · Cited by 35
CAFOs and Surface Water Quality: Evidence from Wisconsin
Raff, Z., & Meyer, A. G. (2019) · American Journal of Agricultural Economics · doi:10.1111/ajae.12222 · Cited by 38
Dietary choline metabolite TMAO impairs cognitive function and induces hippocampal synaptic plasticity declining through the mTOR/P70S6K/4EBP1 pathway
Zhou, S., Liu, J., Sun, Y., Xu, P., Liu, J. L., Sun, S., Zhu, B., & Wu, H. (2023) · Food & Function · doi:10.1039/d2fo03874a · Cited by 34
In Vivo AAV1 Transduction With hRheb(S16H) Protects Hippocampal Neurons by BDNF Production
Jeon, M., Nam, J. H., Shin, W.-H., Leem, E., Jeong, K. H., Jung, U. J., Bae, Y., Jin, Y., Kholodilov, N. G., Burke, R. E., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.241 · Cited by 34
Creatine Supplementation Upregulates mTORC1 Signaling and Markers of Synaptic Plasticity in the Dentate Gyrus While Ameliorating LPS-Induced Cognitive Impairment in Female Rats
Mao, X., Kelty, T. J., Kerr, N. R., Childs, T. E., Roberts, M. D., & Booth, F. W. (2021) · Nutrients · doi:10.3390/nu13082758 · Cited by 36
Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs)
Rios-Fuller, T. J., Mahé, M., Walters, B., Abbadi, D., Pérez-Baos, S., Gadi, A., Andrews, J. J., Katsara, O., Vincent, C. T., & Schneider, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155301 · Cited by 34
APOE4 Affects Basal and NMDAR-Mediated Protein Synthesis in Neurons by Perturbing Calcium Homeostasis
Ramakrishna, S., Jhaveri, V., Konings, S. C., Nawalpuri, B., Chakraborty, S., Holst, B., Schmid, B., Gouras, G. K., Freude, K., & Muddashetty, R. S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0435-21.2021 · Cited by 34
Self-citation
GSK-3β/mTORC1 Couples Synaptogenesis and Axonal Repair to Reduce Hypoxia Ischemia-Mediated Brain Injury in Neonatal Rats
Xiong, T., Qu, Y., Wang, H., Chen, H., Zhu, J., Zhao, F., Zou, R., Zhang, L., & Mu, D. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly015 · Cited by 31
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Jeong, A., Cheng, S., Zhong, R., Bennett, D. A., Bergö, M. O., & Li, L. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01231-5 · Cited by 31
Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs
Santini, E., & Klann, E. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00076 · Cited by 34
Self-citation
Inositol Hexakisphosphate Kinases Induce Cell Death in Huntington Disease
Nagata, E., Saiardi, A., Tsukamoto, H., Okada, Y., Itoh, Y., Satoh, T., Itoh, J., Margolis, R. L., Takizawa, S., Sawa, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220749 · Cited by 33
Understanding the relationship between GSK-3 and Alzheimer’s disease: a focus on how GSK-3 can modulate synaptic plasticity processes
Medina, M., & Ávila, J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.39 · Cited by 33
Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration
Awamlh, S. A. H. A., Wareham, L. K., Risner, M. L., & Calkins, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094672 · Cited by 30
Differing Life History Characteristics Support Coexistence of Tree Soil Generalist and Specialist Species in Tropical Rain Forests
Born, J., Pluess, A. R., Burslem, D. F. R. P., Nilus, R., Maycock, C. R., & Ghazoul, J. (2013) · Biotropica · doi:10.1111/btp.12083 · Cited by 30
Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease
Beckelman, B. C., Zhou, X., Keene, C. D., & Ma, T. (2015) · Neurodegenerative Diseases · doi:10.1159/000438925 · Cited by 32
Self-citation
Increased mitochondrial calcium uptake and concomitant mitochondrial activity by presenilin loss promotes mTORC1 signaling to drive neurodegeneration
Ryan, K. C., Ashkavand, Z., Sarasija, S., Laboy, J. T., Samarakoon, R., & Norman, K. R. (2021) · Aging Cell · doi:10.1111/acel.13472 · Cited by 27
Metformin induces degradation of mTOR protein in breast cancer cells
Alalem, M. A., Ray, A., & Ray, B. K. (2016) · Cancer Medicine · doi:10.1002/cam4.896 · Cited by 27
mTORC1 Is a Local, Postsynaptic Voltage Sensor Regulated by Positive and Negative Feedback Pathways
Niere, F., & Raab‐Graham, K. F. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00152 · Cited by 28
Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome
Martínez‐Cué, C., & Rueda, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186906 · Cited by 26
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 29
From attention-deficit hyperactivity disorder to sporadic Alzheimer’s disease—Wnt/mTOR pathways hypothesis
Grünblatt, E., Homolak, J., Perhoč, A. B., Virag, D., Knezović, A., Barilar, J. O., Riederer, P., Walitza, S., Tackenberg, C., & Šalković‐Petrišić, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1104985 · Cited by 26
The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin Pathway
Lin, L. (2017) · CNS Drugs · doi:10.1007/s40263-017-0431-2 · Cited by 27
Genetic removal of eIF 2α kinase PERK in mice enables hippocampal L‐ LTP independent of mTORC 1 activity
Zimmermann, H. R., Yang, W., Beckelman, B. C., Kasica, N. P., Zhou, X., Galli, L. D., Ryazanov, A. G., & Ma, T. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14306 · Cited by 25
Self-citation
Neurotoxicity of developmental hypothyroxinemia and hypothyroidism in rats: Impairments of long-term potentiation are mediated by phosphatidylinositol 3-kinase signaling pathway
Wang, Y., Wei, W., Wang, Y., Dong, J., Song, B., Min, H., Teng, W., & Chen, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.034 · Cited by 25
PI3K-mTOR-S6K Signaling Mediates Neuronal Viability via Collapsin Response Mediator Protein-2 Expression
Na, E. J., Nam, H. Y., Park, J., Chung, M.-A., Woo, H. A., & Kim, H. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00288 · Cited by 23
Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer’s: a Comprehensive Review
Eskandari, S., Sajadimajd, S., Alaei, L., Soheilikhah, Z., Derakhshankhah, H., & Bahrami, G. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00381-7 · Cited by 24
The role of Wnt/mTOR signaling in spinal cord injury
Peng, C. M., Liao, H.-Y., & Zhang, H. (2022) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2022.101760 · Cited by 24
The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer’s disease pathogenesis
Kim, Y., Kim, C., Son, S. M., Song, H., Hong, H., Han, S.-H., & Mook‐Jung, I. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0068-5 · Cited by 25
APP Causes Hyperexcitability in Fragile X Mice
Westmark, C. J., Chuang, S.-C., Hays, S. A., Filon, M. J., Ray, B. C., Westmark, P. R., Gibson, J. R., Huber, K. M., & Wong, R. K. S. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00147 · Cited by 24
Elucidating the role of DEPTOR in Alzheimer’s disease
Davies, J., Zachariades, E., Rogers‐Broadway, K., & Karteris, E. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1895 · Cited by 22
Shotgun Brain Proteomics Reveals Early Molecular Signature in Presymptomatic Mouse Model of Alzheimer's Disease
Yang, H., Wittnam, J. L., Zubarev, R. A., & Bayer, T. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130476 · Cited by 23
Diverse pathways to neuronal necroptosis in Alzheimer's disease
Jayaraman, A., & Reynolds, R. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15662 · Cited by 21
Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer’s Disease
Beckelman, B. C., Day, S. M., Zhou, X., Donohue, M., Gouras, G. K., Klann, E., Keene, C. D., & Ma, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160036 · Cited by 29
Self-citation
Lithium therapy subdues neuroinflammation to maintain pyramidal cells arborization and rescues neurobehavioural impairments in ovariectomized rats
Rana, A. K., Sharma, S., Patial, V., & Singh, D. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02719-w · Cited by 24
Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies
Dahiya, M., Yadav, M., Goyal, C., & Kumar, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01704-2 · Cited by 22
Alzheimer Disease and Cellular Mechanisms of Memory Storage
Arshavsky, Y. I. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000043 · Cited by 19
Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis
Liu, Z. S.-J., Truong, T. T. T., Bortolasci, C. C., Spolding, B., Panizzutti, B., Swinton, C., Kim, J. H., Kidnapillai, S., Richardson, M. F., Gray, L. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137180 · Cited by 18
Multiple cytoskeletal pathways and PI3K signaling mediate CDC-42-induced neuronal protrusion inC. elegans
Alan, J. K., Struckhoff, E. C., & Lundquist, E. A. (2013) · Small GTPases · doi:10.4161/sgtp.26602 · Cited by 16
Differential Expression Profiles and Functional Prediction of Circular RNAs and Long Non-coding RNAs in the Hippocampus of Nrf2-Knockout Mice
Zhang, R., Li, Y., Liu, Q., Gao, Y., Du, J., Ma, J., Sun, S.-G., & Wang, L. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00196 · Cited by 19
Regulation of aberrant proteasome activity re‐establishes plasticity and long‐term memory in an animal model of Alzheimer's disease
Krishna‐K, K., Baby, N., Raghuraman, R., Navakkode, S., Behnisch, T., & Sajikumar, S. (2020) · The FASEB Journal · doi:10.1096/fj.201902844rr · Cited by 18
A neuroprotective role of Ufmylation through Atg9 in the aging brain of Drosophila
Li, H., Yu, Z., Niu, Z., Cheng, Y., Wei, Z., Cai, Y., Ma, F., Hu, L., Zhu, J., & Zhang, W. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04778-9 · Cited by 16
Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
Gouras, G. K. (2013) · International Journal of Cell Biology · doi:10.1155/2013/141083 · Cited by 17
Self-citation
Presenilin 1 mutation likely contributes to U1 small nuclear RNA dysregulation and Alzheimer's disease–like symptoms
Cheng, Z., Shang, Y., Xu, X., Dong, Z., Zhang, Y., Du, Z., Lu, X., & Zhang, T. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.015 · Cited by 17
mTOR
Child, N. D., & Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000000922 · Cited by 17
Modulation of autophagy as a therapeutic target for Alzheimer’s disease
Steele, J., Fan, E. Y., Kelahmetaglu, Y., Tian, Y., & Bustos, V. (2013) · Postdoc Journal · doi:10.14304/surya.jpr.v1n2.3 · Cited by 16
Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain
Cho, C., Michailidis, V., & Martin, L. J. (2018) · Neurobiology of Pain · doi:10.1016/j.ynpai.2018.03.002 · Cited by 16
Treadmill training attenuate STZ-induced cognitive dysfunction in type 2 diabetic rats via modulating Grb10/IGF-R signaling
Zhang, Y., Chen, D., Zhang, M., Bian, J., Qian, S., & Kou, X. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.01.007 · Cited by 16
Cathepsin K Knockout Exacerbates Haemorrhagic Transformation Induced by Recombinant Tissue Plasminogen Activator After Focal Cerebral Ischaemia in Mice
Zhao, R., He, X., Shi, Y.-H., Liu, Y., Liu, F.-D., Hu, Y., Zhuang, M.-T., Feng, X., Zhao, L., Zhao, B., et al. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00682-8 · Cited by 15
HBO-PC Promotes Locomotor Recovery by Reducing Apoptosis and Inflammation in SCI Rats: The Role of the mTOR Signaling Pathway
Chen, H., Xu, G., Wu, Y., Wang, X., Wang, F., & Zhang, Y. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00921-3 · Cited by 14
The Neuroprotective Beta Amyloid Hexapeptide Core Reverses Deficits in Synaptic Plasticity in the 5xFAD APP/PS1 Mouse Model
Forest, K. H., Taketa, R., Arora, K., Todorovic, C., & Nichols, R. A. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.576038 · Cited by 13
Misfolded protein aggregation and altered cellular pathways in neurodegenerative diseases
Li, H., Yu, Z., & Zhang, W. (2020) · STEMedicine · doi:10.37175/stemedicine.v1i4.63 · Cited by 14
REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment
Yi, J. H., Kwon, H., Cho, E., Jeon, J., Lee, J., Lee, Y. C., Cho, J. H., Jun, M., Moon, M., Ryu, J. H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249482 · Cited by 14
mTOR referees memory and disease through mRNA repression and competition
Raab‐Graham, K. F., & Niere, F. (2017) · FEBS Letters · doi:10.1002/1873-3468.12675 · Cited by 13
Dipeptide IF prevents the effects of hypertension‐induced Alzheimer's disease on long‐term memory in the cortex of spontaneously hypertensive rats
Chang, Y., Kumar, K. A., Ju, D., Ho, T., Mahalakshmi, B., Lin, W., Day, C. H., Padma, V. V., Liao, P., & Huang, C. (2019) · Environmental Toxicology · doi:10.1002/tox.22892 · Cited by 12
mTOR : at the crossroads of aging, chaperones, and A lzheimer's disease
Gouras, G. K. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12098 · Cited by 13
Self-citation
USP9X-mediated deubiquitination of Raptor contributes to autophagy impairment and memory deficits in P301S mice
Zheng, S., Zhu, J., Wang, C., Wu, Y., Sun, S., Guo, H., Chang, Y., Ma, R., & Li, G. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01872-8 · Cited by 12
Multivariate association between single-nucleotide polymorphisms in Alzgene linkage regions and structural changes in the brain: discovery, refinement and validation
Szefer, E., Lu, D., Nathoo, F. S., Beg, M. F., Graham, J., & Initiative, F. T. A. D. N. (2017) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/sagmb-2016-0077 · Cited by 11
Deregulation of Mitochondrial Calcium Handling Due to Presenilin Loss Disrupts Redox Homeostasis and Promotes Neuronal Dysfunction
Ryan, K. C., Laboy, J. T., & Norman, K. R. (2022) · Antioxidants · doi:10.3390/antiox11091642 · Cited by 12
The facilitating effect of MK-801 on inhibitory avoidance memory via mTOR signaling in the mouse hippocampus
Hsiung, M.-H., Huang, W.-L., Kan, L.-Y., Chen, L.-H., & Hu, S. S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112630 · Cited by 12
The mTOR inhibitor rapamycin suppresses trigeminal neuropathic pain and p-MKK4/p-p38 mitogen-activated protein kinase-mediated microglial activation in the trigeminal nucleus caudalis of mice with infraorbital nerve injury
Yeo, J., & Roh, D. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1172366 · Cited by 14
RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
Medd, M. M., Yon, J. E., & Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020124 · Cited by 11
FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines
Liu, F.-L., Liu, T. “., & Kung, F. (2014) · Journal of Biosciences · doi:10.1007/s12038-013-9400-1 · Cited by 11
G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation
Melick, C. H., Lama-Sherpa, T. D., Curukovic, A., & Jewell, J. L. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000302 · Cited by 11
Inhibition of mammalian target of rapamycin complex 1 in the brain microvascular endothelium ameliorates diabetic Aβ brain deposition and cognitive impairment via the sterol‐regulatory element‐binding protein 1/lipoprotein receptor‐associated protein 1 signaling pathway
Jiang, G., Long, Z., Wang, Y., Wang, Y., Xue, P., Chen, M., Yang, K., & Li, W. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14133 · Cited by 10
Role of amyloid β protein receptors in mediating synaptic plasticity
Li, Y., Sun, Z., Cao, Q., Chen, M., Luo, H., Lin, X., & Xiao, F. (2017) · Biomedical Reports · doi:10.3892/br.2017.863 · Cited by 11
The anaesthetic xenon partially restores an amyloid beta-induced impairment in murine hippocampal synaptic plasticity
Buerge, M., Kratzer, S., Mattusch, C., Hofmann, C., Kreuzer, M., Parsons, C. G., & Rammes, G. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.031 · Cited by 12
A strategic tool to improve the study of molecular determinants of Alzheimer’s disease: The role of glyceraldehyde
Piccirillo, S., Preziuso, A., Cerqueni, G., Serfilippi, T., Terenzi, V., Vinciguerra, A., Amoroso, S., Lariccia, V., & Magi, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115869 · Cited by 10
Unraveling the role of proteins in dementia: insights from two UK cohorts with causal evidence
Gong, J., Williams, D. M., Scholes, S., Assaad, S., Bu, F., Hayat, S. A., Zaninotto, P., & Steptoe, A. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf097 · Cited by 17
mTOR and Neuroinflammation
Palavra, F., Ambrósio, A. F., & Reis, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00002-5 · Cited by 12
A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro
Querfurth, H., Marshall, J., Parang, K., Rioult-Pedotti, M. S., Tiwari, R., Kwon, B., Reisinger, S., & Lee, H.-K. (2022) · PLOS ONE · doi:10.1371/journal.pone.0261696 · Cited by 9
Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease
Gouras, G. K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00185 · Cited by 10
Self-citation
In Silico Prediction of Quercetin Analogs for Targeting Death-Associated Protein Kinase 1 (DAPK1) Against Alzheimer’s Disease
Sun, Y., Zhao, J. W., Lu, Y., Ngo, F. Y., Shuai, B., Zhang, Z., Feng, Y., & Rong, J. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240515090434 · Cited by 8

Authors: Ma, T., Hoeffer, C. A., Capetillo-Zarate, E., Yu, F., Wong, H., Lin, M. T., Tampellini, D., Klann, E., Blitzer, R. D., & Gouras, G. K.
Affiliations: Weill Cornell Medicine (US)
New York University (US)
Icahn School of Medicine at Mount Sinai (US)
Corresponding author: Gouras, Gunnar K.
ORCID: Ma, Tao
Hoeffer, Charles A.
Wong, Helen
Tampellini, Davide
Klann, Eric
Blitzer, Robert D.
Gouras, Gunnar K.
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2010-09-20
Volume: 5
Issue: 9
Pages: e12845
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0012845
PMC: PMC2942840
OpenAlex: W2071279551
Cited by: 262
References: 52
Citations by year: 2026: 9 · 2025: 12 · 2024: 7 · 2023: 13 · 2022: 13 · 2021: 20 · 2020: 26 · 2019: 10 · 2018: 11 · 2017: 14 · 2016: 18 · 2015: 17 · 2014: 30 · 2013: 23 · 2012: 22
FWCI: 13.22
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Communities in ADDI (University of the Basque Country) (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Figshare (submittedVersion, cc-by)
Hispana (submittedVersion, cc-by)
Lund University Publications (Lund University) (submittedVersion)
Funders: National Institutes of Health (N S03400 7, AG‐09464, AG28174)
National Institute on Aging (R01AG027140, AG09464, R01AG020729, K02AG028174, AG28174, AG027140, P01AG009464)
National Institute of General Medical Sciences (R01GM054508, GM-054508)
National Institute of Neurological Disorders and Stroke (R37NS034007, R01NS034007, R29NS034007, NS-034007)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: mTOR signaling, Alzheimer's disease, synaptic plasticity, amyloid-beta, amyloid-beta 42, long-term potentiation, glycogen synthase kinase-3, GSK-3 inhibitors, FKBP12, hippocampus, synaptic dysfunction, intraneuronal amyloid-beta
MeSH terms: Alzheimer Disease, Animals, Disease Models, Animal, Hippocampus, Humans, Mice, Inbred C57BL, Neuronal Plasticity, Peptide Fragments, Synapses, Signal Transduction, Amyloid beta-Peptides, Long-Term Potentiation, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks